- Home
- Protocols
-
Ask a
question
The study protocol was approved by the Institutional Review Board of the study hospital. Signed informed consent was obtained from all participants in the study.
A total of 26 consecutive patients with multilevel DCM (≥ 3) were prospectively enrolled between October 2018 and May 2019. Patients with a history of other spinal disorders, neurological injury, infection, tumor, and rheumatoid arthritis were excluded. Finally, 22 patients (17 males and 5 females) who had been followed for 12 months were included in this study. The mean age at surgery was 61.2 ± 10.8 years and the average symptom duration was 42.95 ± 40.05 months (Table 1).
*Data are mean ± standard deviation.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question
